Dip.io Home Based Dipstick Analyzer
DeviceFirst intervention (assigned to the "All participants" arm).
NCT Number: NCT02785445
The objectives of the Healthy.io Method Comparison and User Performance Study are:
1. To evaluate the performance of Dip.io Device in comparison to the ACON U500 Mission® U500 Urine Analyzer. 2. To evaluate the user performance of Dip.io Device under actual use conditions (home environment) based on a user questionnaire and rating scale.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Atlanta Center for Medical Research, Atlanta, Georgia, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
First intervention (assigned to the "All participants" arm).
Second intervention (assigned to the "All participants" arm).
Time frame: Through study completion, an average of 1 month
The primary objective of the study is to evaluate the exact agreement and the ±1 color block match of the Dip.io compared to the predicate device, for each analyte concentration (block).
Time frame: Through study completion, an average of 1 month
All subjects tested should be able to complete device related tasks. The healthcare professionals also recorded their assessment of each subject's use of the new device.
The subjects and healthcare inputs were recorded using study questionnaires.
Healthy.io Ltd.
Industry
A Comparative, Controlled Study to Evaluate the Clinical Accuracy and User Performance of the Dip Home-Based Dipstick Analyzer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02856633
Acute Otitis Media, Arrhythmias, Cardiac
Oakville, Ontario, Canada
View Trial DetailsNCT01050465
Acne Vulgaris, Acneiform Eruptions
View Trial DetailsNCT00634608
Allergic Rhinitis, Anxiety
Columbia, Missouri, United States
View Trial DetailsNCT06059846
Acute Pyelonephritis, Female Urogenital Diseases
Miami, Florida, United States
View Trial Details